277 related articles for article (PubMed ID: 10651142)
1. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.
Nakazi M; Bauer U; Nickel T; Kathmann M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):19-24. PubMed ID: 10651142
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice.
Kathmann M; Weber B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):50-6. PubMed ID: 11191836
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
Kathmann M; Bauer U; Schlicker E; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.
Schultheiss T; Flau K; Kathmann M; Göthert M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):139-46. PubMed ID: 16195872
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus.
Schlicker E; Timm J; Zentner J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):583-9. PubMed ID: 9402037
[TBL] [Abstract][Full Text] [Related]
6. Mutual interactions of the presynaptic histamine H3 and prostaglandin EP3 receptors on the noradrenergic terminals in the mouse brain.
Schlicker E; Marr I
Neuroscience; 1997 Jul; 79(1):247-54. PubMed ID: 9178880
[TBL] [Abstract][Full Text] [Related]
7. A search for presynaptic beta3-adrenoceptors in the rat.
Zelaszczyk D; Zakrzeska A; Kwolek G; Malinowska B; Schlicker E
Fundam Clin Pharmacol; 2005 Apr; 19(2):147-53. PubMed ID: 15810894
[TBL] [Abstract][Full Text] [Related]
8. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
Schlicker E; Fink K; Molderings GJ; Price GW; Duckworth M; Gaster L; Middlemiss DN; Zentner J; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):321-7. PubMed ID: 9303568
[TBL] [Abstract][Full Text] [Related]
9. H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain.
Timm J; Marr I; Werthwein S; Elz S; Schunack W; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):232-9. PubMed ID: 9550293
[TBL] [Abstract][Full Text] [Related]
10. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ
Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515
[TBL] [Abstract][Full Text] [Related]
11. Enhanced acetylcholine release in the hippocampus of cannabinoid CB(1) receptor-deficient mice.
Kathmann M; Weber B; Zimmer A; Schlicker E
Br J Pharmacol; 2001 Mar; 132(6):1169-73. PubMed ID: 11250865
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor-mediated inhibition of dopamine release in the retina.
Schlicker E; Timm J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):791-5. PubMed ID: 8971741
[TBL] [Abstract][Full Text] [Related]
13. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors.
Schlicker E; Werthwein S; Kathmann M; Bauer U
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):418-22. PubMed ID: 9826063
[TBL] [Abstract][Full Text] [Related]
14. Serotonin release in the rat brain cortex is inhibited by neuropeptide Y but not affected by ACTH1-24, angiotensin II, bradykinin and delta-sleep-inducing peptide.
Schlicker E; Gross G; Fink K; Glaser T; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb; 343(2):117-22. PubMed ID: 1648670
[TBL] [Abstract][Full Text] [Related]
15. Involvement of presynaptic H3 receptors in the inhibitory effect of histamine on serotonin release in the rat brain cortex.
Fink K; Schlicker E; Neise A; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):513-9. PubMed ID: 1965326
[TBL] [Abstract][Full Text] [Related]
16. Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro.
Werthwein S; Bauer U; Nakazi M; Kathmann M; Schlicker E
Br J Pharmacol; 1999 May; 127(1):300-8. PubMed ID: 10369486
[TBL] [Abstract][Full Text] [Related]
17. Lack of CB1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release.
Schlicker E; Redmer A; Werner A; Kathmann M
Br J Pharmacol; 2003 Sep; 140(2):323-8. PubMed ID: 12970076
[TBL] [Abstract][Full Text] [Related]
18. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
Bühlen M; Fink K; Böing C; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
[TBL] [Abstract][Full Text] [Related]
20. Identification of presynaptic 5-HT1 autoreceptors in pig brain cortex synaptosomes and slices.
Fink K; Schlicker E; Betz R; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):14-8. PubMed ID: 3237252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
